Fine and specialty chemicals in the pharmaceutical sector contribute to the overall healthcare systems worldwide, as they provide rare materials which are further purified and processed to manufacture the pharmaceutical products and health related products consumed. Not only is demand for drugs continuing to increase but as the importance and need for biotechnology increases, this specific market is also growing. The demand for healthcare and healthcare related products continues to expand, particularly in emerging economies. Companies in this arena are producing the highest quality and most consistent chemicals (at competitive price points), which are the key to developing Active Pharmaceutical Ingredients (APIs), intermediates and excipients. The industry has had and will continue to have vigorous growth, and has significant room to grow as the needs for drug and generic drug development grow. Demand for fine chemicals is growing mostly due to the demand for specialty medicines, as chronic Diseases like diabetes, cancer and cardiovascular are increasing in incidence.

Also, pharmaceutical companies are outsourcing their production to Contract Development and Manufacturing Organizations (CDMOs)/ A series of new opportunities for growth. The industry, however, is confronted with some challenges, such as regulatory consideration, increased quality control scrutiny, and fluctuations in costs for raw materials. Sustainability and...